Stryker Reports Revenue Growth of 10.3% in Second Quarter
Stryker (SYK) released its second-quarter results on July 24. The company’s net sales surged 10.3% from $3.01 billion in Q2 2017 to $3.3 billion in Q2 2018. Stryker’s Neurotechnology and Spine segment, which grew by 19.4%, contributed the most to Stryker’s revenue growth. Sales from its other two segments, Orthopaedics and MedSurg, grew by 7.6% and 8.9%, respectively. The increase in the company’s revenues came from higher unit volumes, partially offset by lower prices.